In addition, dopamine receptor agonists, catechol O-methyltransferase inhibitors, monoamine oxidase B (MAOB) inhibitors, amantadine and anticholinergic drugs are available on the market for the treatment of PD [7,8]. Here, MAOB is linked to Parkinson disease.